Thomson Medical's FY2024 Earnings Plunges 57.8% to $15.4m
Thomson Medical's FY2024 Earnings Plunges 57.8% to $15.4m
Revenue for the period slightly dropped 1.3% YoY to $351.2m.Earnings per share stood at $0.058.
每股收益爲0.058美元。
Thomson Medical Group (TMG) reported a 57.8% year-on-year (YoY) decline in earnings for FY2024 to $15.4m from $36.5m a year ago.
湯姆森醫療集團（TMG）報告稱，FY2024 的收益同比下降57.8％，從去年同期的3650萬美元降至1,540萬美元。
Net profit for the period also slumped 52.5% YoY to $19.5m from $41.1m in FY2023.
該期間的淨利潤也從 FY2023 的4,110萬美元同比下降了52.5％，至1,950萬美元。
Revenue for the period slightly dropped 1.3% YoY to $351.2m.
該期間的收入同比略有下降1.3％，至3.512億美元。
The group's EBITDA also slipped 0.9% YoY to $102.4m from $103.3m a year ago, impacted by long-term operations investments, lower income from COVID-19-related projects, and costs and foreign exchange losses from the acquisition of FV Hospital (FEMVN).
該集團的息稅折舊攤銷前利潤也從去年同期的1.033億美元同比下降0.9％至1.024億美元，這受到長期運營投資、COVID-19相關項目收入減少以及收購FV醫院（FEMVN）的成本和外匯損失的影響。
Earnings per share stood at $0.058 from $0.138 in the previous period.
每股收益爲0.058美元，高於上一時期的0.138美元。
譯文內容由第三人軟體翻譯。
